Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
SYRE · against 174 other Healthcare companies of similar size
Ranked #10 of 175 · scores higher than 95% of peers · safety percentile 94
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)14 peers with a safety percentile of 90–100, including SYRE · Click a bar to see the companies
Mainly thanks to its current ratio, which is stronger than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | SYRE | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 170 reported | Not reported | 0.33× | — | — | 33% |
| BetaLower is better · 176 reported | 3.00 | 0.57 | 1% | 33% | |
| Current ratioHigher is better · 166 reported | 18.53× | 2.44× | 95% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 10.1B EUR (≈$11.1B) | 99 | ||
| 4 | 9.0B USD | 98 | 51 | |
| 5 | 4.6B USD | 98 | 29 | |
| 6 | 5.7B USD | 97 | 52 | |
| 7 | 10.2B USD | 97 | ||
| 8 | 9.8B USD | 96 | ||
| 9 | 5.2B USD | 94 | 74 | |
| 10 | 8.8B USD | 94 | 50 | |
| 11 | 9.1B USD | 92 | 74 | |
| 12 | 7.7B USD | 92 | 36 | |
| 13 | 5.4B USD | 91 | 38 | |
| 14 | 4.8B USD | 90 | 27 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score